Kwang Woo Ahn, PhD

Associate Professor

Locations

Biostatistics

Contact Information

Education

PhD, The University of Iowa, Iowa City, IA, 2008
MS, The University of Iowa, Iowa City, IA, 2005
BS, Korea University, Seoul, Republic of Korea, 2003

Research Areas of Interest

Biostatistics
Clinical Trial
Controlled Clinical Trial
Data Accuracy
Data Interpretation, Statistical
Machine Learning

Research Experience

Survival and competing risks data analysis, high dimensional data analysis, missing data, bioinformatics, personalized medicine

Research Interests

Dr. Kwang Woo Ahn is an Associate Professor in the Division of Biostatistics at the Medical College of Wisconsin. He joined the division in the fall of 2008. He has been collaborating with various research groups at MCW including Center for International Blood & Marrow Transplant Research (CIBMTR), Department of Physiology, and Department of Plastic Surgery. In CIBMTR, he is serving as PhD statistician of several working committees including Chronic Leukemia, Lymphoma, and Pediatric Cancer. He is involved in projects on hypertension, next generation sequencing data from Physiology. His current research interest includes survival analysis and variable selection.

Curriculum Vitae

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

(Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Ortí G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W.) Transplant Cell Ther. 2022 04;28(4):187.e1-187.e10 PMID: 35081472 PMCID: PMC8977261 SCOPUS ID: 2-s2.0-85125344790 01/27/2022
Competing risks regression models with covariates-adjusted censoring weight under the generalized case-cohort design.

(Xu Y, Kim S, Zhang MJ, Couper D, Ahn KW.) Lifetime Data Anal. 2022 04;28(2):241-262 PMID: 35034255 PMCID: PMC8977245 SCOPUS ID: 2-s2.0-85123103100 01/17/2022
A calibrated Bayesian method for the stratified proportional hazards model with missing covariates.

(Kim S, Kim JK, Ahn KW.) Lifetime Data Anal. 2022 04;28(2):169-193 PMID: 35034213 PMCID: PMC8977246 SCOPUS ID: 2-s2.0-85123120385 01/17/2022
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.

(Shadman M, Pasquini M, Ahn KW, Chen Y, Turtle CJ, Hematti P, Cohen JB, Khimani F, Ganguly S, Merryman RW, Yared JA, Locke FL, Ahmed N, Munshi PN, Beitinjaneh A, Reagan PM, Herrera AF, Sauter CS, Kharfan-Dabaja MA, Hamadani M.) Blood. 2022 03 03;139(9):1330-1339 PMID: 34570879 PMCID: PMC8900276 SCOPUS ID: 2-s2.0-85125439632 09/28/2021
Incidence rate of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among nurses in coronavirus disease 2019 (COVID-19) units versus non-COVID-19-units at a large academic medical center.

(Rivera F, Huerta S, Ahn KW, Munoz-Price LS.) Infect Control Hosp Epidemiol. 2022 02;43(2):257-259 PMID: 34338169 PMCID: PMC8367872 08/03/2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.

(Riedell PA, Hamadani M, Ahn KW, Litovich C, Brunstein CG, Cashen AF, Cohen JB, Epperla N, Hill BT, Im A, Inwards DJ, Lister J, McCarty JM, Ravi Kiran Pingali S, Shadman M, Shaughnessy P, Solh M, Stiff PJ, Vose JM, Kharfan-Dabaja MA, Herrera AF, Sauter CS, Smith SM.) Br J Haematol. 2021 12;195(5):757-763 PMID: 34581433 PMCID: PMC8627449 SCOPUS ID: 2-s2.0-85115835960 09/29/2021
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.

(Riedell PA, Hamadani M, Ahn KW, Litovich C, Murthy GSG, Locke FL, Brunstein CG, Merryman RW, Stiff PJ, Pawarode A, Nishihori T, Kharfan-Dabaja MA, Herrera AF, Sauter CS, Smith SM.) Transplant Cell Ther. 2021 11;27(11):911.e1-911.e7 PMID: 34450333 PMCID: PMC8556305 SCOPUS ID: 2-s2.0-85116436482 08/28/2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.

(Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W.) Transplant Cell Ther. 2021 11;27(11):921.e1-921.e10 PMID: 34403791 SCOPUS ID: 2-s2.0-85121157621 08/18/2021
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.

(Herrera AF, Ahn KW, Litovich C, Chen Y, Assal A, Bashir Q, Bayer RL, Coleman M, DeFilipp Z, Farhadfar N, Greenwood M, Hahn T, Horwitz M, Jacobson C, Jaglowski S, Lachance S, Langston A, Mattar B, Maziarz RT, McGuirk J, Mian MAH, Nathan S, Phillips A, Rakszawski K, Sengeloev H, Shenoy S, Stuart R, Sauter CS, Kharfan-Dabaja MA, Hamadani M.) Blood Adv. 2021 09 28;5(18):3528-3539 PMID: 34496026 PMCID: PMC8945575 SCOPUS ID: 2-s2.0-85116143497 09/09/2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.

(Scordo M, Wang TP, Ahn KW, Chen Y, Ahmed S, Awan FT, Beitinjaneh A, Chen A, Chow VA, Dholaria B, Epperla N, Farooq U, Ghosh N, Grover N, Hamad N, Hildebrandt GC, Holmberg L, Hong S, Inwards DJ, Jimenez-Jimenez A, Karmali R, Kenkre VP, Khimani F, Klyuchnikov E, Krem MM, Munshi PN, Nieto Y, Prestidge T, Ramakrishnan Geethakumari P, Rezvani AR, Riedell PA, Seo S, Shah NN, Solh M, Yared JA, Kharfan-Dabaja MA, Herrera A, Hamadani M, Sauter CS.) JAMA Oncol. 2021 Jul 01;7(7):993-1003 PMID: 33956047 PMCID: PMC8283558 SCOPUS ID: 2-s2.0-85105866863 05/07/2021
Predicting asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection rates of inpatients: A time-series analysis.

(Rivera F, Ahn KW, Munoz-Price LS.) Infect Control Hosp Epidemiol. 2021 Jun 24:1-4 PMID: 34162451 PMCID: PMC8280390 06/25/2021
Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.

(He Y, Kim S, Kim MO, Saber W, Ahn KW.) Comput Stat Data Anal. 2021 Jun;158 PMID: 33994608 PMCID: PMC8117077 05/18/2021

Biostatistics